Gadoterate meglumine
Sponsors
Guerbet, University of Campinas, Brazil, University of Southern California, University of Massachusetts, Worcester, Bayer
Conditions
Breast Cancer FemaleBreast DiseasesCentral Nervous System PathologyCognitive FunctionContrast Enhancement in Magnetic Resonance ImagingContrast MediaCoronary AtherosclerosisDoxorubicin Induced Cardiomyopathy
Phase 2
Phase 3
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)
CompletedNCT05915728
Start: 2023-07-24End: 2024-06-01Updated: 2025-12-22
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems
CompletedNCT05915702
Start: 2023-07-24End: 2024-05-31Updated: 2025-08-17
Phase 4
Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
CompletedNCT01254552
Start: 2010-08-31End: 2016-10-31Updated: 2019-05-31
DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
TerminatedNCT01806740
Start: 2013-05-09End: 2015-10-12Updated: 2019-08-08
Dotarem vs Gadobutrol Contrast for Breast MRI
CompletedNCT03730051
Start: 2021-03-01End: 2025-12-31Updated: 2026-03-17
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecruitingNCT04373564
Start: 2021-03-24End: 2028-12-31Target: 2076Updated: 2026-01-22
Unknown Phase
Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
CompletedNCT03000036
Start: 2012-07-31End: 2016-07-31Updated: 2016-12-21
QSM and Regional DCE MRI Permeability Using GOCART Technique
WithdrawnNCT03091803
Start: 2017-04-04End: 2021-04-04Updated: 2021-04-05
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
RecruitingNCT05937776
Start: 2023-12-11End: 2025-12-31Target: 20Updated: 2025-11-07